US/UK/Canada

Share

Contacts

  • Daniel Vallin

    CEO and IR contact


    +46730686620
    http://cellimpact.com

    • Links

    Pick a time period -
    Tags ( Active)

    NOTICE OF THE EXTRAORDINARY GENERAL MEETING OF CELL IMPACT AB (PUBL)

    The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in the Extraordinary General Meeting to be held on Friday 31 July 2026 at 10.30 hours (CET) at the premises of Wåhlin Advokater AB, Nybrogatan 39 in Stockholm, Sweden. Registration starts at 10.00 hours (CET).Registration and notificationA shareholder who wishes to participate in the Extraordinary General Meeting in person or by proxy:  - must be recorded as a shareholder in the share register maintained by Euroclear Sweden AB regarding the circumstances on 23 July 2026,  - must no

    Cell Impact resolves on a rights issue of units of approximately SEK 53.6 million and procures a bridge loan of SEK 15 million

    THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THE INFORMATION WOULD NOT COMPLY WITH APPLICABLE RULES OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE ANY SECURITIES IN CELL IMPACT AB (PUBL). PLEASE ALSO SEE THE "IMPORTANT INFORMATION" SECTION BELOW. THIS PRESS RELEASE HAS

    Cell Impact receives order worth SEK 5.3 million

    Cell Impact AB (publ) has received an order, worth SEK 5.3 million, from a major PEM fuel cell and electrolyzer OEM based in Northeast USA.The order relates to the manufacture and supply of existing flow plates already developed and will be used in the customer's established operations. Deliveries are scheduled to take place over the next two years, with the first delivery expected in the third quarter of 2026. "We are pleased to continue our manufacturing for a customer with whom we have worked for many years. The order serves as a baseline order for future deliveries and covers

    Cell Impact reports limited liquidity following delayed transaction

    Cell Impact has in recent years described the market as cautious, characterised by delays. Today, Cell Impact reports a further delay.Sales of machinery has in recent times been a complementary area of focus. The current delay relates to a substantial transaction concerning the sale of a large number of machines. “Our unique forming technology formed the basis of this agreement, and we had strong and realistic expectations of completing the transaction in June. Unfortunately, delays arose in the customer’s project, which materialised at a very late stage of the negotiations,” says Daniel

    Cell Impact Q1 2026: Measured progress in a turbulent hydrogen market

    During the quarter Cell Impact continued its work on ongoing customer projects and made progress in line with its updated strategy, with an increased focus on expanding the business and future high-volume production.Net sales for the quarter increased to SEK 2.2 million (1.9) compared with the same quarter in 2025. The operating loss amounted to SEK –16.6 million (–20.8). “It is worth mentioning that we continued to display high levels of cost awareness, and that the adaptation of our operations continued to have a clear impact on our costs,” said Daniel Vallin, CEO of Cell Impact.

    Communiqué from the Annual General Meeting 2026 of Cell Impact AB (publ)

    The annual general meeting of Cell Impact AB (publ) was held on 23 April 2026.Adoption of the profit and loss account and balance sheet as well as profit allocationThe annual general meeting approved the balance sheets and income statements included in the annual report for the financial year 2025 and resolved, in accordance with the proposal of the board of directors, that available profits of SEK 57,360,520 should be carried forward. Board of directors and auditorThe annual general meeting granted the directors of the board and the CEO discharge from liability for the financial

    NOTICE OF THE ANNUAL GENERAL MEETING OF CELL IMPACT AB (PUBL)

    The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in the annual general meeting to be held on Thursday 23 April 2026, 14.00 hours (CET) at the premises of Sturegatan 15 by Hantverket on Sturegatan 15 in Stockholm, Sweden. Registration starts at 13.30 hours (CET).Registration and notificationA shareholder who wishes to participate in the annual general meeting: · must be recorded as a shareholder in the share register maintained by Euroclear Sweden AB regarding the circumstances on 15 April 2026; · must no later than 17 April 2026

    Cell Impact publishes annual report for 2025

    Although the global market remained weak during the year, 2025 marked a breakthrough in the areas that are most important to Cell Impact. Cost control, project deliveries and deeper partner and customer relationships strengthened the company’s position.In 2025, Cell Impact continued to lay the foundations for the company’s survival and to strengthen its market position. “In the fourth quarter of 2025, we announced a strategic cooperation agreement with thyssenkrupp Automation Engineering, one of Europe’s leading industrial players in advanced automation equipment. In 2025, we also

    Last day of trading in Cell Impact BTA – conversion of BTA into shares

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH DISCLOSURE, PUBLICATION OR DISTRIBUTION WOULD BE IN CONFLICT WITH APPLICABLE REGULATIONS OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.Cell Impact AB’s (publ) (“Cell

    Cell Impact carries out a directed share issue to guarantors and a directed issue of warrants to lender

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS INFORMATION WOULD BE IN CONTRAVENTION OF APPLICABLE REGULATIONS OR WOULD REQUIRE REGISTRATION OR ANY OTHER ACTION. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE “IMPORTANT INFORMATION” SECTION BELOW.Cell Impact AB

    Cell Impact in replacement agreement, receives 6 MSEK

    In 2024, Cell Impact entered into an agreement concerning flow plates, forming tools and fixtures with a European manufacturer, with a total contract value of SEK 18 million. Due to delays in the project, no products have been delivered to date. The parties have now agreed to replace the previous agreement with a new one, under which the customer will pay Cell Impact SEK 6 million for activities already carried out.Under the original agreement, payment was to be made on an ongoing basis as compensation for delivered flow plates, but as project deliveries have been delayed, no such payments

    Cell Impact announces outcome of rights issue

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH DISCLOSURE, PUBLICATION OR DISTRIBUTION WOULD BE IN CONFLICT WITH APPLICABLE REGULATIONS OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.Cell Impact AB (publ) (the “

    Cell Impact publishes information document regarding the rights issue

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH DISCLOSURE, PUBLICATION OR DISTRIBUTION WOULD BE IN CONFLICT WITH APPLICABLE REGULATIONS OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.Cell Impact AB (publ) (the “

    Cell Impact Q4 2025: Growth and expansion of the business paving the way forward

    In addition to a number of exciting agreements and new developments, 2025 ended with the announcement of a new share issue and our intention to diversify our operations to broaden our unique expertise into industrial areas other than fuel cells and electrolyzers.Our efforts to lay the foundation for future volume orders intensified in 2025. Ongoing projects proceeded according to plan, and we are making progress that is steadily bringing us closer to large-scale flow plate production. Together with one of our customers, we have transitioned into an initial phase of continuous production,

    Communiqué from the Extraordinary General Meeting of Cell Impact AB (publ)

    Cell Impact AB (publ) held an Extraordinary General Meeting on Friday 30 January 2026. Below is a summary of the resolutions that were made. The resolutions were made in accordance with the proposals presented in the notice convening the Extraordinary General Meeting.Rights issue, etc. The General Meeting resolved to approve the Board of Directors’ resolution of 22 December 2025 on a rights issue of approximately SEK 38.3 million, whereby a maximum of 294,584,745 shares shall be issued. The subscription price amounts to SEK 0.13 per share. Each existing share entitles the holder to one (

    Notice of the extraordinary general meeting of Cell Impact AB (publ)

    The shareholders of Cell Impact AB (publ), reg. no. 556576-6655, are hereby invited to participate in the Extraordinary General Meeting to be held on Friday 30 January 2026 at 10.30 hours (CET) at the premises of Wåhlin Advokater AB, Nybrogatan 39 in Stockholm, Sweden. Registration starts at 10.00 hours (CET).Registration and notificationA shareholder who wishes to participate in the Extraordinary General Meeting in person or by proxy: -            must be recorded as a shareholder in the share register maintained by Euroclear Sweden AB regarding the circumstances on 22 January 2026,

    Cell Impact resolves on a rights issue of approximately SEK 38.3 million, secures a bridge loan, and diversifies its operations toward additional industrial segments

    THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH DISCLOSURE, PUBLICATION OR DISTRIBUTION WOULD BE IN CONFLICT WITH APPLICABLE REGULATIONS OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN CELL IMPACT AB (PUBL). SEE ALSO THE SECTION “IMPORTANT INFORMATION” BELOW.Cell Impact AB (publ) (the “

    Cell Impact to deliver tool to leading automotive manufacturer

    Cell Impact has signed an agreement with a leading Asian automotive manufacturer for the production and delivery of a forming tool used in the manufacturing of flow plates. The order is valued at SEK 1.5 million, with delivery expected during Q1 2026.The automotive manufacturer and Cell Impact have collaborated for several years through multiple customer projects, and this latest agreement is the result of previous successful initiatives. "Each successful project has brought us one step closer to continuous production. The tool in question will be used by the customer to manufacture

    Cell Impact named Europe’s flow plate manufacturer of the year

    Cell Impact has been recognized as Flow Plate Manufacturer of the Year in Europe 2025 by the industry publication Energy Tech Review.The award, based on feedback from European fuel cell and electrolyzer manufacturers, reflects two key factors: the company’s unique and patented Cell Impact Forming ™ technology, and its fully integrated production line. “We have refined the entire process—forming, cutting, welding, and leak testing—over several years, delivering more than 2.5 million flow plates across 80 projects,” says Daniel Vallin, CEO of

    Cell Impact has been awarded gold medal by EcoVadis

    Last year, Cell Impact was awarded silver by EcoVadis. This year, the company has received a gold medal.EcoVadis, the world’s most trusted provider of sustainability ratings, has evaluated Cell Impact’s operational sustainability practices. The overall score has improved from 72 to 79 of 100, which places the company among the top 5 percent of all rated companies. “The increase is primarily due to improvements in reporting, but also in routines and follow-up across several areas. This isn’t rocket science—we set goals, follow up, and continuously improve,” says Daniel Vallin, CEO of Cell

    Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement

    Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen. The agreement includes a shared ambition to carry out joint marketing activities as well as technical development of flow plates and manufacturing processes for fuel cells and electrolyzers.thyssenkrupp Automation Engineering is a business unit of the automotive segment of the industrial group thyssenkrupp. With a focus on drive and battery assembly systems – particularly for electric mobility – the company offers high-quality, innovative

    Cell Impact Q3 2025: Positioned to gear up for future business

    Cell Impact has gradually improved the ability to scale up production. After the end of the quarter, the company announced a transaction that marked that the project had transitioned to continuous production.Sales in the third quarter remained weak. Net sales totalled SEK 0.4 million (5.5). Earnings for the quarter remained negative at SEK –21.7 million. Cell Impact’s long-term efforts have led to a gradual improvement in the ability to scale up production. - After the end of the quarter, we announced a transaction that marked our exit from the development phase of the project in

    Cell Impact begins continuous production for North American customer

    Following a development phase, Cell Impact has received an initial order for flow plates from a North American customer—an important milestone marking the transition from development to continuous production.The order includes a small quantity of flow plates and has limited impact on cash flow and earnings. Despite its modest size, the deal is strategically significant as it confirms that the project is now entering a production phase, with the goal of gradually increasing volumes. “The agreement is a confirmation that the market is starting to move in the right direction, despite long

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media